The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...
TipRanks on MSN
Vistin Pharma to Announce Q3 2025 Financial Results
Vistin Pharma ASA ( ($DE:VP4) ) has shared an announcement. Vistin Pharma ASA announced it will release its third quarter and ...
Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the ...
Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2025 results on Friday 31st of October 2025. Vistin Pharma will host a conference call for all shareholders and interested parties on ...
The latest announcement is out from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H ( ($HK:1276) ). Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Hydromorphone HCl 10mg/mL; soln for IV, IM or SC inj; preservative-free; contains sulfites. Hydromorphone is a full opioid agonist and is relatively selective for the mu receptor, although it can bind ...
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback